{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T21:22:26Z","timestamp":1776201746326,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,9,2]],"date-time":"2008-09-02T00:00:00Z","timestamp":1220313600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1007\/s10875-008-9233-0","type":"journal-article","created":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T17:01:40Z","timestamp":1220288500000},"page":"210-214","source":"Crossref","is-referenced-by-count":144,"title":["Serum Levels of IL-17 and IL-22 Are Reduced by Etanercept, but not by Acitretin, in Patients with Psoriasis: a Randomized-Controlled Trial"],"prefix":"10.1007","volume":"29","author":[{"given":"M.","family":"Caproni","sequence":"first","affiliation":[]},{"given":"E.","family":"Antiga","sequence":"additional","affiliation":[]},{"given":"L.","family":"Melani","sequence":"additional","affiliation":[]},{"given":"W.","family":"Volpi","sequence":"additional","affiliation":[]},{"given":"E.","family":"Del Bianco","sequence":"additional","affiliation":[]},{"given":"P.","family":"Fabbri","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2008,9,2]]},"reference":[{"key":"9233_CR1","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nature05663","volume":"445","author":"MA Lowes","year":"2007","unstructured":"Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature 2007;445:866\u201373. doi: 10.1038\/nature05663 .","journal-title":"Nature"},{"key":"9233_CR2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.it.2004.03.006","volume":"25","author":"O Boyman","year":"2004","unstructured":"Boyman O, Conrad C, Tonel G, Gilliet M, Nestle FO. The pathogenic role of tissue-resident immune cells in psoriasis. Trends Immunol 2004;25:295\u2013305. doi: 10.1016\/j.it.2004.03.006 .","journal-title":"Trends Immunol"},{"key":"9233_CR3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/1523-1747.ep12371752","volume":"102","author":"JF Schlaak","year":"1994","unstructured":"Schlaak JF, Buslau M, Jochum W, Hermann E, Girndt M, Gallati H, et al. T cells involved in psoriasis vulgaris belong to the Th1 subset. J Invest Dermatol 1994;102:145\u20139. doi: 10.1111\/1523-1747.ep12371752 .","journal-title":"J Invest Dermatol"},{"key":"9233_CR4","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1084\/jem.20071094","volume":"204","author":"LC Zaba","year":"2007","unstructured":"Zaba LC, Cardinale I, Gilleaudeau P, Sullivan-Whalen M, Su\u00e1rez Fari\u00f1as M, Fuentes-Duculan J, et al. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med 2007;204:3183\u201394. doi: 10.1084\/jem.20071094 .","journal-title":"J Exp Med"},{"key":"9233_CR5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2249.2007.03511.x","volume":"150","author":"K Boniface","year":"2007","unstructured":"Boniface K, Guignouard E, Pedretti N, Garcia M, Delwail A, Bernard FX, et al. A role for T cell-derived interleukin 22 in psoriatic skin inflammation. Clin Exp Immunol 2007;150:407\u201315.","journal-title":"Clin Exp Immunol"},{"key":"9233_CR6","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature05505","volume":"445","author":"Y Zheng","year":"2007","unstructured":"Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J, Ouyang W. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007;445:648\u201351. doi: 10.1038\/nature05505 .","journal-title":"Nature"},{"key":"9233_CR7","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/eji.200535503","volume":"36","author":"K Wolk","year":"2006","unstructured":"Wolk K, Witte E, Wallace E, D\u00f6cke WD, Kunz S, Asadullah K, et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol 2006;36:1309\u201323. doi: 10.1002\/eji.200535503 .","journal-title":"Eur J Immunol"},{"key":"9233_CR8","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.4049\/jimmunol.176.3.1908","volume":"176","author":"G Piskin","year":"2006","unstructured":"Piskin G, Sylva-Steenland RM, Bos JD, Teunissen MB. In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin. J Immunol 2006;176:1908\u201315.","journal-title":"J Immunol"},{"key":"9233_CR9","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1007\/BF02832018","volume":"24","author":"J Li","year":"2004","unstructured":"Li J, Li D, Tan Z. The expression of interleukin-17, interferon-gamma, and macrophage inflammatory protein-3 alpha mRNA in patients with psoriasis vulgaris. J Huazhong Univ Sci Technolog Med Sci 2004;24:294\u20136.","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"9233_CR10","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s11596-007-0329-1","volume":"27","author":"J Li","year":"2007","unstructured":"Li J, Chen X, Liu Z, Yue Q, Liu H. Expression of Th17 cytokines in skin lesions of patients with psoriasis. J Huazhong Univ Sci Technolog Med Sci 2007;27:330\u20132. doi: 10.1007\/s11596-007-0329-1 .","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"9233_CR11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1084\/jem.20030451","volume":"199","author":"E Lee","year":"2004","unstructured":"Lee E, Trepicchio WL, Oestreicher JL, Pittman D, Wang F, Chamian F, Dhodapkar M, Krueger JG. Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med 2004;199:125\u201330. doi: 10.1084\/jem.20030451 .","journal-title":"J Exp Med"},{"key":"9233_CR12","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","volume":"128","author":"MA Lowes","year":"2008","unstructured":"Lowes MA, Kikuchi T, Fuentes-Duculan J, Cardinale I, Zaba LC, Haider AS, Bowman EP, Krueger JG. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 2008;128:1207\u201311. doi: 10.1038\/sj.jid.5701213 .","journal-title":"J Invest Dermatol"},{"key":"9233_CR13","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1146\/annurev.immunol.25.022106.141557","volume":"25","author":"CT Weaver","year":"2007","unstructured":"Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell linear. Annu Rev Immunol 2007;25:821\u201352. doi: 10.1146\/annurev.immunol.25.022106.141557 .","journal-title":"Annu Rev Immunol"},{"key":"9233_CR14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/eji.200425677","volume":"35","author":"S Vanden-Eijnden","year":"2005","unstructured":"Vanden-Eijnden S, Goriely S, De Wit D, Willems F, Goldman M. IL-23 up-regulates IL-10 and induces IL-17 synthesis by polyclonally activated naive T cells in human. Eur J Immunol 2005;35:469\u201375. doi: 10.1002\/eji.200425677 .","journal-title":"Eur J Immunol"},{"key":"9233_CR15","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.coi.2006.09.008","volume":"18","author":"K Kikly","year":"2006","unstructured":"Kikly K, Liu L, Na S, Sedgwick JD. The IL-23\/Th17 axis: therapeutic targets for autoimmune inflammation. Curr Opin Immunol 2006;18:670\u20135. doi: 10.1016\/j.coi.2006.09.008 .","journal-title":"Curr Opin Immunol"},{"key":"9233_CR16","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1210\/jc.2007-2190","volume":"93","author":"AK Huber","year":"2008","unstructured":"Huber AK, Jacobson EM, Jazdzewski K, Concepcion ES, Tomer Y. IL-23R is a major susceptibility gene for Graves\u2019 ophthalmopathy: the IL-23\/Th17 axis extends to thyroid autoimmunity. J Clin Endocrinol Metab 2008;93:1077\u201381. doi: 10.1210\/jc.2007-2190 .","journal-title":"J Clin Endocrinol Metab"},{"key":"9233_CR17","doi-asserted-by":"crossref","first-page":"566","DOI":"10.4049\/jimmunol.177.1.566","volume":"177","author":"Y Komiyama","year":"2006","unstructured":"Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Kakuta S, et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 2006;177:566\u201373.","journal-title":"J Immunol"},{"key":"9233_CR18","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1084\/jem.20070663","volume":"204","author":"F Annunziato","year":"2007","unstructured":"Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B, et al. Phenotypic and functional features of human Th17 cells. J Exp Med 2007;204:1849\u201361. doi: 10.1084\/jem.20070663 .","journal-title":"J Exp Med"},{"key":"9233_CR19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.clim.2007.01.006","volume":"123","author":"BF Chong","year":"2007","unstructured":"Chong BF, Wong HK. Immunobiologics in the treatment of psoriasis. Clin Immunol 2007;123:129\u201338. doi: 10.1016\/j.clim.2007.01.006 .","journal-title":"Clin Immunol"},{"key":"9233_CR20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/sj.jidsymp.5650037","volume":"12","author":"JK Tan","year":"2007","unstructured":"Tan JK, Aphale A, Malaviya R, Sun Y, Gottlieb AB. Mechanisms of action of etanercept in psoriasis. J Investig Dermatol Symp Proc 2007;12:38\u201345. doi: 10.1038\/sj.jidsymp.5650037 .","journal-title":"J Investig Dermatol Symp Proc"},{"key":"9233_CR21","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1529-8019.2006.00082.x","volume":"19","author":"PCM Kerkhof van de","year":"2006","unstructured":"van de Kerkhof PCM. Update of retinoid therapy of psoriasis in: an update on the use of retinoids in dermatology. Dermatol Ther 2006;19:252\u201363. doi: 10.1111\/j.1529-8019.2006.00082.x .","journal-title":"Dermatol Ther"},{"key":"9233_CR22","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1517\/14656566.8.5.617","volume":"8","author":"A Leon","year":"2007","unstructured":"Leon A, Nguyen A, Letsinger J, Koo J. An attempt to formulate an evidence-based strategy in the management of moderate-to-severe psoriasis: a review of the efficacy and safety of biologics and prebiologic options. Expert Opin Pharmacother 2007;8:617\u201332. doi: 10.1517\/14656566.8.5.617 .","journal-title":"Expert Opin Pharmacother"},{"key":"9233_CR23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1155\/MI.2005.273","volume":"2005","author":"O Arican","year":"2005","unstructured":"Arican O, Aral M, Sasmaz S, Ciragil P. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm 2005;2005:273\u20139. doi: 10.1155\/MI.2005.273 .","journal-title":"Mediators Inflamm"},{"key":"9233_CR24","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.4049\/jimmunol.173.5.3482","volume":"173","author":"CY Kao","year":"2004","unstructured":"Kao CY, Chen Y, Thai P, Wachi S, Huang F, Kim C, et al. IL-17 markedly up-regulates beta-defensin-2 expression in human airway epithelium via JAK and NF-kappa B signaling pathways. J Immunol 2004;173:3482\u201391.","journal-title":"J Immunol"},{"key":"9233_CR25","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.4049\/jimmunol.174.6.3695","volume":"174","author":"K Boniface","year":"2005","unstructured":"Boniface K, Bernard FX, Garcia M, Gurney AL, Lecron JC, Morel F. IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J Immunol 2005;174:3695\u2013702.","journal-title":"J Immunol"},{"key":"9233_CR26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","volume":"21","author":"K Wolk","year":"2004","unstructured":"Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R. IL-22 increases the innate immunity of tissues. Immunity 2004;21:241\u201354. doi: 10.1016\/j.immuni.2004.07.007 .","journal-title":"Immunity"},{"key":"9233_CR27","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1096\/fasebj.10.9.8801161","volume":"10","author":"GJ Fisher","year":"1996","unstructured":"Fisher GJ, Voorhees JJ. Molecular mechanisms of retinoid actions in skin. FASEB J 1996;10:1002\u201313.","journal-title":"FASEB J"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-008-9233-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-008-9233-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-008-9233-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T04:10:04Z","timestamp":1559275804000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-008-9233-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["9233"],"URL":"https:\/\/doi.org\/10.1007\/s10875-008-9233-0","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9,2]]}}}